Enrolling Clinical Studies
Enrolling Clinical Trials
Gastroenterology
Non-Alcoholic Steatohepatitis (NASH)
A Phase 3 study sponsored by Akero Therapeutics to evaluate the safety & efficacy of Efruxifermin in patients with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Fibrosis.
You may qualify for this no-cost clinical trial if you:
- Are 18+ years of age
- Have been diagnosed with NASH (fibrosis Score F2-F3)
Metabolic Dysfuction-Associated Steatohepatitis (MASH & F2/F3 Fibrosis) / FASCINATE-3
A Phase 3 study sponsored by Sagimet Biosciences evaluating the safety & efficacy of Denifanstat in patients with Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH).
You may qualify for this no-cost clinical trial if you:
- Are 18+ years of age
- Have been diagnosed with MASH and F2/F3 Fibrosis
Metabolic Dysfuction-Associated Steatohepatitis (MASLD/MASH) / FASCINIT
A Phase 3 study sponsored by Sagimet Biosciences evaluating the safety & efficacy of Denifanstat in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)/Metabolic Dysfunction-Associated Steatohepatitis (MASH).
You may qualify for this no-cost clinical trial if you:
- Are 18+ years of age
- Have been diagnosed with MASLD/MASH
Ulcerative Colitis (UC) with an Eosinophilic Phenotype / LIBERTY-UC SUCCEED)
A Phase 2 study to study the efficacy & safety of Dupilumab in patients with moderate to severe active Ulcerative Colitis with an eosinophilic phenotype.
You may qualify for this no-cost clinical trial if you:
- Are 18+ years of age
- Have been diagnosed with Ulcerative Colitis (UC)
Infectious Disease
California NeuroHIV Tissue Network
An NIH sponsored research study in collaboration with UC San Diego (UCSD) to learn more about physical and mental effects of HIV disease. Research visits may take place at UCSD and/or Palmtree Clinical Research, Inc. This project includes tissue donation via autopsy for HIV + & non-HIV+ participants.
Pulmonology
Idiopathic Pulmonary Fibrosis (IPF) / BEACON
A Phase 2B study sponsored by Pliant Therapeutics to evaluate the efficacy & safety of Bexotegrast for the treatment of Idiopathic Pulmonary Fibrosis (IPF)
Lung Cancer Screening Collection Study (LIGHTHOUSE)
A prospective, multi-center study designed to enroll participants who are eligible for lung cancer screening.
You may qualify for this no-cost clinical trial if you:
- Are 18+ years of age
- Are scheduled for a Low-Dose Computed Tomography (LDCT) scan
Health insurance and doctor referrals are not required to participate in the clinical trials & clinical studies.